IVV | TCAF | IVV / TCAF | |
Gain YTD | -0.828 | -0.962 | 86% |
Net Assets | 572B | 4.34B | 13,168% |
Total Expense Ratio | 0.03 | 0.31 | 10% |
Turnover | 3.00 | 14.30 | 21% |
Yield | 1.39 | 0.45 | 307% |
Fund Existence | 25 years | 2 years | - |
IVV | TCAF | |
---|---|---|
RSI ODDS (%) | 2 days ago80% | 2 days ago63% |
Stochastic ODDS (%) | 2 days ago78% | 2 days ago68% |
Momentum ODDS (%) | 4 days ago90% | 4 days ago89% |
MACD ODDS (%) | 3 days ago88% | 2 days ago78% |
TrendWeek ODDS (%) | 2 days ago76% | 2 days ago68% |
TrendMonth ODDS (%) | 2 days ago86% | 2 days ago81% |
Advances ODDS (%) | 6 days ago86% | 6 days ago87% |
Declines ODDS (%) | 4 days ago76% | 4 days ago63% |
BollingerBands ODDS (%) | 2 days ago78% | 2 days ago85% |
Aroon ODDS (%) | 2 days ago82% | 2 days ago84% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DEHP | 26.82 | 0.20 | +0.75% |
Dimensional Em Mkts High Prof ETF | |||
BNDI | 46.18 | 0.06 | +0.14% |
NEOS Enhanced Income Aggregate Bond ETF | |||
QAI | 31.80 | N/A | N/A |
NYLI Hedge Multi-Strategy Tracker ETF | |||
XBI | 79.04 | -0.29 | -0.37% |
SPDR® S&P Biotech ETF | |||
TGLR | 29.73 | -0.29 | -0.95% |
LAFFER|TENGLER Equity Income ETF |
A.I.dvisor indicates that over the last year, TCAF has been closely correlated with ANSS. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCAF jumps, then ANSS could also see price increases.
Ticker / NAME | Correlation To TCAF | 1D Price Change % | ||
---|---|---|---|---|
TCAF | 100% | -0.69% | ||
ANSS - TCAF | 78% Closely correlated | -0.24% | ||
ADSK - TCAF | 71% Closely correlated | +0.12% | ||
CDNS - TCAF | 69% Closely correlated | -0.35% | ||
MSFT - TCAF | 68% Closely correlated | -1.03% | ||
AMZN - TCAF | 66% Closely correlated | -0.06% | ||
More |